Letter to the editor: Immune dysregulation in new-onset refractory status epilepticus (NORSE): current insights and therapeutic perspectives. Aphale P, Dokania S, Shekhar H. Brain Dev 2025;47:104422.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aphale P, Dokania S, Shekhar H. Letter to the editor: Immune dysregulation in new-onset refractory status epilepticus (NORSE): current insights and therapeutic perspectives. Brain Dev 2025;47:104422.
PMID: 40834618